ARCHIVES

FDA Oncologic Drug Committee Agrees That “Kitty Fight” With NCI Should Be Negotiated

This article is from The Cancer Letter archive.

Vol. 01 No. 48 | November 28, 1975

Download PDF Visit The Full Archive

Related Articles

NCI Picks 11 Centers For Chemical Biology Consortium

October 23, 2009

NCI Trials Listed

June 25, 2010

PR firm Ketchum serves two clients on Medicare issues: CMS and ASCO. HHS policy officials weren’t told about potential conflict, department spokesman says.

September 24, 2004

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

November 18, 2011

New Law Allows Texans To Self-Refer To M.D. Anderson

December 1, 1995